Insmed Inc $ 35.77 -1.39 (-3.74%)
Volume:
978,903
Avg Vol (1m):
818,822
Market Cap $:
3.64 Bil
Enterprise Value $:
3.45 Bil
PE Ratio:
0.00
PB Ratio:
10.20
Financial Strength | 4/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 1.47 | ||
| Equity-to-Asset | 0.43 | ||
| Debt-to-Equity | 1.12 | ||
| Debt-to-EBITDA | -1.99 | ||
| Piotroski F-Score | 5 | ||
| Altman Z-Score | 1.83 | ||
| Beneish M-Score | -2.49 | ||
| WACC vs ROIC | |||
Profitability Rank | 1/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | -129.09 | ||
| Net Margin % | -145.14 | ||
| ROE % | -79.77 | ||
| ROA % | -31.33 | ||
| ROC (Joel Greenblatt) % | -205.12 | ||
| 3-Year EBITDA Growth Rate | 2.3 | ||
| 3-Year EPS without NRI Growth Rate | -1.8 |
INSM
Valuation Rank |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PB Ratio | 10.2 | ||
| PS Ratio | 19.97 | ||
| EV-to-EBIT | -16.01 | ||
| EV-to-EBITDA | -17.2 | ||
| EV-to-Revenue | 20.48 | ||
| Current Ratio | 7.95 | ||
| Quick Ratio | 7.43 | ||
| Days Inventory | 312.06 | ||
| Days Sales Outstanding | 32.88 | ||
| Days Payable | 214.33 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -13.1 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | 11.84 | ||
| Earnings Yield (Greenblatt) % | -6.25 |